Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...

Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our ...

After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...

A recent study highlights the alarming increase in death risk associated with respiratory syncytial virus (RSV) among adults.

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...

The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...